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Identity 
Other names: DKFZp686J1497; FAP-1; PNP1; PTP-
BAS; PTP-BL; PTP-E1; PTP1E; PTPL1; PTPLE 
HGNC (Hugo): PTPN13 
Location: 4q21.3 
Note: Genomic context: PTPN13 lies in a head-to-head 
conformation with MAPK10/JNK3 and they share a 
633 bp bi-directional promoter which is a typical CpG 
island. 
DNA/RNA 
Description 
The gene covers 220.87 kb (from 87734485 to 
87955350-NCBI) and contains 48 exons and 51 
different introns (49 gt-ag, 2 gc-ag), initiates 
transcription within exon 2 and terminates in exon 48. 
Transcription 
Transcription produces 13 different mRNAs, 9 
alternatively spliced variants and 4 unspliced forms. 
RefSeq annotates 4 representative transcripts, but 
Homo sapiens cDNA sequences in GenBank support at 
least 9 spliced variants. 
 
 
Protein 
Description 
The protein encoded by this gene is a member of the 
protein tyrosine phosphatase (PTP) family. PTPs are 
known to be signaling molecules that regulate a variety 
of cellular processes including cell growth, 
differentiation, mitotic cycle, and oncogenic 
transformation. This PTP is a large protein that 
possesses a PTP domain at C-terminus, and multiple 
noncatalytic domains, which include a domain with 
similarity to band 4.1 superfamily of cytoskeletal-
associated proteins, a region consisting of five PDZ 
domains, and a leucine zipper motif. This PTP was 
found to interact with, and dephosphorylate Fas 
receptor, as well as IkappaBalpha through the PDZ 
domains, which suggested its role in Fas mediated 
programmed cell death. This PTP was also shown to 
interact with GTPase-activating protein, and thus may 
function as a regulator of Rho signaling pathway. Eight 
spliced and the unspliced mRNAs putatively encode 
good proteins. 
Expression 
In all human normal tissues, including lymph node and 
peripheral blood mononuclear cells samples, PTPN13 
is ubiquitously expressed. 
 
 
Genomic view. 
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Schematic representation of PTPN13 structure and boxes represent functional domains. The KIND domain has been identified in silico 
by sequence homology. 
 
Localisation 
The FERM domain binds to phosphatidylinositol 4,5-
biphosphate leading to the enrichment of PTPN13 at a 
juxtamembrane localization.However, the PTPN13 
protein is also detected throughout the cytoplasm. In 
HeLa cells, PTPN13 localizes to the centrosomes 
during metaphase. 
Function 
Functionally, the gene has been tested for association to 
diseases (bone neoplasms; carcinoma; colorectal 
neoplasms; liver neoplasms; lymphoma; sarcoma, 
Ewing's), proposed to participate in a pathway (FAS 
signaling pathway (CD95)) and a process (protein 
amino acid dephosphorylation). Proteins are expected 
to have molecular functions (non-membrane spanning 
protein tyrosine phosphatase activity, hydrolase 
activity, protein binding, structural molecule activity) 
and to localize in various compartments (nucleus, 
cytoplasm, cytoskeleton). 
Mutations 
Note 
Different somatic mutations was identified in colorectal 
tumors (19% of the colorectal cancer  
samples analyzed), predicted to result in missense or 
non-sense mutations. Some of these mutant proteins led 
to reduce phosphatase activity. 
Implicated in 
Colorectal cancers 
Disease 
A large-scale study that looked at the mutations in the 
tyrosine phosphatome from colorectal cancers 
identified PTPN13. The authors identified 19 
mutations, non-sense and missense, seven of which 
were in the PTP domain. 
Lymphomas (Hodgkin and non-
Hodgkin), gastric and hepatocellular 
tumors 
Disease 
Hypermethylation of the PTPN13 promoter or allelic 
loss was observed leading to downregulation of 
PTPN13 mRNA. 
To be noted 
Note 
Several evidences suggest that PTPN13 may act  
 
Distribution of mutations in PTPN13, black arrows indicate location of missense mutations, red arrows indicate location of nonsense 
mutations or frameshifts. 
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differently as a tumor promoting gene depending upon 
the disease context. The modulation of Fas-mediated 
cell death by PTPN13 could enhance tumor growth by 
blocking death signaling. 
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